Bio-Techne Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Bio-Techne stock has a consensus rating of "Hold" and an average price target of $70. The average 1-year stock price forecast is 1.62% lower than the current stock price, while the lowest is $50 (-29.73%) and the highest is $73 (+2.60%).

Price Target: $70 (-1.62%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$50	$70	$73	$73
Change	-29.73%	-1.62%	+2.60%	+2.60%

Analyst Ratings

The average analyst rating for Bio-Techne stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	10	9	9	9	3	2
Buy	1	1	1	2	1	0
Hold	4	4	4	4	11	13
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	14	14	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dan Leonard RBC Capital	RBC Capital	Hold Downgrades $62 → $73	Hold	Downgrades	$62 → $73	+2.60%	Jul 9, 2026
Kyle Boucher TD Cowen	TD Cowen	Hold Downgrades $65 → $73	Hold	Downgrades	$65 → $73	+2.60%	Jul 1, 2026
Robert Wasserman Benchmark Co.	Benchmark Co.	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 30, 2026
Patrick B Donnelly Citi	Citi	Hold Downgrades $70 → $73	Hold	Downgrades	$70 → $73	+2.60%	Jun 29, 2026
Steven Etoch Stephens	Stephens	Hold Downgrades $68 → $73	Hold	Downgrades	$68 → $73	+2.60%	Jun 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.21B

from 1.22B

-0.86%

from 1.22B

Revenue Next Year

1.26B

from 1.21B

4.59%

from 1.21B

EPS This Year

1.92

from 1.92

-0.04%

from 1.92

EPS Next Year

2.05

from 1.92

6.57%

from 1.92

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Jun 30, 2021	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026
Revenue	931.03M	1.11B	1.14B	1.16B	1.22B	1.21B
Revenue Growth	26.04%	18.75%	2.81%	1.97%	5.23%	-0.86%
Gross Profit	634.42M	758.09M	770.22M	773.80M	811.12M	830.99M
Gross Margin	68.14%	68.57%	67.76%	66.76%	66.50%	68.72%
Operating Income	251.40M	279.06M	281.11M	248.61M	265.24M	389.09M
Net Income	140.41M	272.05M	285.26M	168.11M	73.40M	184.70M
EPS	-	-	-	-	1.92	1.92
EPS Growth	-	-	-	-	8.47%	-0.04%
Forward PE	61.93	39.55	36.57	36.72	25.74	37.07
Dividend / Share	0.32	0.32	0.32	0.32	0.32	0.32
Dividend Growth	-	-	-	-	-	-
Free Cash Flow	257.40M	214.22M	184.46M	214.19M	313.92M	278.74M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	1.2B
Avg	1.2B
Low	1.2B

Revenue Growth

Revenue Growth	2026	2027	2028
High	-0.3%
Avg	-0.9%
Low	-1.2%

EPS Forecast

EPS	2026	2027	2028
High	1.94
Avg	1.92
Low	1.86

EPS Growth

EPS Growth	2026	2027	2028
High	1.0%
Avg	-0.0%
Low	-3.1%